Beaton Management Company’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Beaton Management Company’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$258K	Hold	2,022	–	–	0.11%	129
2025 Q4	$247K	Sell	2,022 -28	-1%	-$3.21K	0.11%	132
2025 Q3	$205K	Buy	+2,050	New	+$185K	0.09%	142
2024 Q4	–	Sell	-2,150	Closed	-$212K	–	136
2024 Q3	$212K	Buy	+2,150	New	+$211K	0.11%	133
2022 Q1	–	Sell	-2,190	Closed	-$245K	–	147
2021 Q4	$245K	Hold	2,190	–	–	0.15%	129
2021 Q3	$275K	Hold	2,190	–	–	0.18%	117
2021 Q2	$297K	Hold	2,190	–	–	0.19%	112
2021 Q1	$297K	Hold	2,190	–	–	0.21%	106
2020 Q4	$308K	Sell	2,190 -60	-3%	-$7.68K	0.23%	100
2020 Q3	$251K	Hold	2,250	–	–	0.21%	102
2020 Q2	$252K	Buy	+2,250	New	+$222K	0.22%	97
2020 Q1	–	Sell	-2,250	Closed	-$214K	–	121
2019 Q4	$214K	Buy	+2,250	New	+$195K	0.17%	118
2019 Q3	–	Sell	-2,300	Closed	-$202K	–	122
2019 Q2	$202K	Sell	2,300 -100	-4%	-$8.53K	0.17%	115
2019 Q1	$217K	Buy	+2,400	New	+$204K	0.19%	113
2018 Q4	–	Sell	-2,350	Closed	-$225K	–	120
2018 Q3	$225K	Buy	2,350 +50	+2%	+$4.85K	0.19%	113
2018 Q2	$219K	Buy	+2,300	New	+$211K	0.2%	113

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Beaton Management Company's XBI Position: Q1 2026 in Review

Beaton Management Company held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q1 2026 at 2,022 shares worth $258K. The position accounts for 0.11% of the portfolio, ranked #129.

Beaton Management Company first reported a position in XBI in Q2 2018 and has held it in 16 quarters since. The position peaked at $308K in Q4 2020. 814 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

Beaton Management Company held 2,022 shares of State Street SPDR S&P Biotech ETF worth $258K as of Q1 2026.
Beaton Management Company left its State Street SPDR S&P Biotech ETF share count unchanged in Q1 2026.
State Street SPDR S&P Biotech ETF made up 0.11% of Beaton Management Company's portfolio in Q1 2026, its #129 holding.
Beaton Management Company first reported a position in State Street SPDR S&P Biotech ETF in Q2 2018 and has held it in 16 quarters since.
Beaton Management Company's State Street SPDR S&P Biotech ETF position peaked at $308K in Q4 2020.
814 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Beaton Management Company's 13F filing for Q1 2026, filed 12 May 2026.